These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 8163804

  • 1. Neuroleptic malignant syndrome presenting without initial fever: a case report.
    Totten VY, Hirschenstein E, Hew P.
    J Emerg Med; 1994; 12(1):43-7. PubMed ID: 8163804
    [Abstract] [Full Text] [Related]

  • 2. Neuroleptic malignant syndrome.
    Rampertaap MP.
    South Med J; 1986 Mar; 79(3):331-6. PubMed ID: 3513330
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Neuroleptic malignant syndrome--a cautionary tale and a surprising outcome.
    Cape G.
    Br J Psychiatry; 1994 Jan; 164(1):120-2. PubMed ID: 8137093
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
    Khouri C, Planès S, Logerot S, Villier C, Mallaret M.
    Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
    [Abstract] [Full Text] [Related]

  • 9. An unusual presentation of neuroleptic malignant syndrome.
    Basu J.
    J Indian Med Assoc; 1991 Jan; 89(1):16. PubMed ID: 2051035
    [Abstract] [Full Text] [Related]

  • 10. [Neuroleptic malignant syndrome : Rare cause of fever of unknown origin].
    Chackupurakal R, Wild U, Kamm M, Wappler F, Reske D, Sakka SG.
    Anaesthesist; 2015 Jul; 64(7):527-31. PubMed ID: 26122200
    [Abstract] [Full Text] [Related]

  • 11. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
    Liu PY, Wu PC, Chen CY, Chen YC.
    Gen Hosp Psychiatry; 2011 Jul; 33(1):84.e5-7. PubMed ID: 21353143
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The evaluation and management of patients with neuroleptic malignant syndrome.
    Bhanushali MJ, Tuite PJ.
    Neurol Clin; 2004 May; 22(2):389-411. PubMed ID: 15062519
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Catatonia and Neuroleptic Malignant Syndrome in Patients With Cerebral Palsy: Two Case Reports and a Systematic Review of the Literature.
    Barnett BS, Balaji D, Weleff J, Carroll BT.
    J Acad Consult Liaison Psychiatry; 2023 May; 64(3):277-293. PubMed ID: 36586471
    [Abstract] [Full Text] [Related]

  • 16. Fluphenazine-induced neuroleptic malignant syndrome in a schizophrenic patient.
    Aruna AS, Murungi JH.
    Ann Pharmacother; 2005 Jun; 39(6):1131-5. PubMed ID: 15840734
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of a mild form of neuroleptic malignant syndrome with oral diazepam.
    Kontaxakis VP, Christodoulou GN, Markidis MP, Havaki-Kontaxaki BJ.
    Acta Psychiatr Scand; 1988 Sep; 78(3):396-8. PubMed ID: 3195360
    [Abstract] [Full Text] [Related]

  • 19. [Clozapine-associated neuroleptic malignant syndrome followed by catatonia: a case report].
    Erol A, Putgül G, Sert E, Mete L.
    Turk Psikiyatri Derg; 2013 Sep; 24(2):140-4. PubMed ID: 23754268
    [Abstract] [Full Text] [Related]

  • 20. Recognizing neuroleptic malignant syndrome in the emergency department: a case study.
    Agar L.
    Perspect Psychiatr Care; 2010 Apr; 46(2):143-51. PubMed ID: 20377802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.